Quarterly report pursuant to Section 13 or 15(d)

Supplemental Financial Statement Information

v3.20.1
Supplemental Financial Statement Information
 3 Months Ended
Mar. 31, 2020
Payables and Accruals [Abstract]  
Supplemental Financial Statement Information SUPPLEMENTAL FINANCIAL STATEMENT INFORMATION
Accrued Expenses and Other Current Liabilities
The following table summarizes the composition of accrued expenses and other current liabilities as of the dates indicated:
March 31, 2020 December 31, 2019
(in thousands)
Accrued expenses and other current liabilities:
Payroll related including bonus $ 1,662    $ 1,314   
Contingent consideration 922    1,568   
Accrued marketing fees and royalties 681    304   
Refund liability 664    622   
Accrued purchase price consideration for business acquisition 218    3,029   
Current portion of long-term debt 181    178   
Other 4,161    3,585   
$ 8,489    $ 10,600   
Customer Deposits
Our product offerings include premium, patented, child-resistant packaging, closed-system vaporization solutions and custom-branded retail products. For these product offerings, we generally receive a deposit from the customer (generally 50% of the total order cost, but the amount can vary by customer contract), when an order is placed by a customer. We typically complete orders related to customer deposits within six weeks to three months from the date of order, depending on the complexity of the customization and the size of the order. Changes in our customer deposits liability balance during the three months ended March 31, 2020 were as follows:
(in thousands) Customer Deposits
Balance as of December 31, 2019 $ 3,152   
Increases due to deposits received, net of other adjustments 2,792   
Revenue recognized (3,361)  
Balance as of March 31, 2020 $ 2,583   
Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss during the three months ended March 31, 2020 were as follows:
(in thousands) Foreign Currency Translation Unrealized
Loss on Derivative Instrument		 Total
Balance at December 31, 2019 $ (22)   $ (50)   $ (72)  
Other comprehensive loss (627)   (493)   (1,120)  
Less: Other comprehensive loss attributable to
non-controlling interest		 477    376    853   
Balance at March 31, 2020 $ (172)   $ (167)   $ (339)  

Changes in accumulated other comprehensive loss during the three months ended March 31, 2019 were as follows:
(in thousands) Foreign Currency Translation Unrealized
Loss on Derivative
Instrument		 Total
Balance at December 31, 2018 $ (286)   $ —    $ (286)  
Other comprehensive income 28    —    28   
Balance at March 31, 2019 $ (258)   $ —    $ (258)  
Supplier Concentration
We have three major vendors whose products accounted for an aggregate of approximately 35.8% of our total net sales and 40.1% of our total purchases for the three months ended March 31, 2020, and an aggregate of approximately 57.0% of our total net sales and 57.5% of our total purchases for the three months ended March 31, 2019. We expect to maintain our existing relationships with these vendors.